What is the appropriate workup for a patient with worsening renal function?

Workup for Worsening Kidney Function

Begin with serum creatinine measurement and urinalysis with microscopy to determine if the decline is acute (hours to days), subacute (7-90 days), or chronic (>3 months), as this fundamentally directs your diagnostic approach and urgency of intervention 1, 2.

Initial Assessment Framework

Establish Timing and Severity

• Acute Kidney Injury (AKI): Creatinine increase ≥0.3 mg/dL within 48 hours OR ≥1.5× baseline within 7 days OR urine output <0.5 mL/kg/h for 6 hours 3
• Acute Kidney Disease (AKD): Kidney dysfunction persisting 7-90 days after initial insult 3, 4
• Chronic Kidney Disease (CKD): Kidney damage or eGFR <60 mL/min/1.73m² for ≥3 months 5, 1

Critical distinction: Use absolute serum creatinine values (not eGFR) when assessing day-to-day changes during acute illness, as eGFR equations assume steady-state conditions that don't exist in acute settings 6.

Mandatory Initial Laboratory Workup

Core tests to order immediately 5, 2:

• Serum creatinine with calculation of eGFR using creatinine-based equation (eGFRcr)
• Complete urinalysis with microscopic examination
• Urine albumin-to-creatinine ratio (ACR) or protein-to-creatinine ratio (PCR)
• Electrolytes (sodium, potassium, bicarbonate)
• Complete blood count
• Fractional excretion of sodium (FENa) if prerenal vs. intrinsic etiology unclear

Add cystatin C measurement when 1, 2:

• Extremes of muscle mass (sarcopenia, bodybuilders)
• eGFRcr near critical decision thresholds (e.g., 30 or 60 mL/min/1.73m²)
• Discrepancy between clinical picture and creatinine-based estimates
• Then calculate eGFRcr-cys for more accurate assessment

Classify the Etiology

Prerenal (Hemodynamic)

Look for 7, 8:

• Volume depletion: decreased oral intake, vomiting, diarrhea, diuretic overuse
• Decreased effective circulating volume: heart failure, cirrhosis, sepsis
• Medications: NSAIDs, ACE inhibitors/ARBs (especially combined with diuretics)
• FENa typically <1% (unless on diuretics)

Intrinsic Renal

Urinalysis findings are diagnostic 6, 2:

• Glomerular: Dysmorphic RBCs, RBC casts, acanthocytes, proteinuria >500 mg/g
• Tubular (ATN): Muddy brown casts, granular casts, tubular epithelial cells
• Interstitial: WBCs, WBC casts, eosinophils (drug-induced)
• Vascular: May have bland sediment with acute decline

Additional serologic testing when intrinsic disease suspected 2:

• ANA, complement (C3, C4), ANCA, anti-GBM antibodies
• Serum and urine protein electrophoresis with immunofixation
• Serum free light chains (even without known myeloma)

Postrenal (Obstruction)

Renal ultrasound is mandatory 2, 7, 9:

• Perform in virtually all patients, especially men >50 years
• Look for hydronephrosis, bladder distention, prostate enlargement
• Caveat: Early obstruction (<24-48 hours) or retroperitoneal fibrosis may not show hydronephrosis

Context-Specific Considerations

In Heart Failure Patients

Mild creatinine fluctuations ≤30% from baseline are common and should be observed, not aggressively treated 10. However, oliguria or increases >30% require action 10.

Key principle: In volume-overloaded patients with rising creatinine during diuresis, achieving decongestion takes priority—transient creatinine increases during effective decongestion do not independently predict poor outcomes if congestion resolves 11. The real danger is persistent congestion, not the creatinine rise itself.

Reversible factors to address immediately 10:

• Systemic hypotension
• Volume depletion (paradoxically can occur with diuretics)
• Nephrotoxic medications: NSAIDs, excessive RAAS inhibition
• Assess for venous congestion causing renal dysfunction

Medication Review is Non-Negotiable

Stop or adjust 10, 6:

• NSAIDs and COX-2 inhibitors
• Aminoglycosides and other nephrotoxins
• Consider holding ACE inhibitors/ARBs if creatinine increases >30% (but restart once stable)
• Adjust all renally-cleared medications for current eGFR

Surveillance Strategy

Frequency of Monitoring

During acute deterioration 10:

• Daily creatinine and electrolytes in hospitalized patients
• Within 1-3 days after significant diuretic adjustment in advanced disease
• Within 7 days for any significant medication change affecting kidneys

Post-AKI follow-up 4, 12:

• Measure creatinine within 3 months of AKI episode for all patients
• Earlier follow-up (2-4 weeks) for incomplete recovery or AKD stage 2-3
• Include urine ACR measurement—not just creatinine
• More intensive surveillance for patients with pre-existing CKD, diabetes, heart failure, or recurrent AKI

Risk Stratification for Nephrology Referral

Refer to nephrology when 5, 13:

• eGFR <30 mL/min/1.73m² (CKD stage 4-5)
• Urine ACR >300 mg/g or PCR >500 mg/g persistently
• Rapid decline: eGFR decrease >5 mL/min/1.73m² per year
• AKI requiring or potentially requiring dialysis
• Unclear etiology despite initial workup
• Active urinary sediment suggesting glomerulonephritis

Common Pitfalls to Avoid

1. Don't rely on serum creatinine alone in elderly or sarcopenic patients—they may have advanced CKD with "normal" creatinine due to low muscle mass 6. Use cystatin C or measure GFR directly.

2. Don't assume chronicity from a single abnormal value—could be AKI or AKD 1. Verify with prior values or repeat testing.

3. Don't withhold nephroprotective therapies (RAAS inhibitors, SGLT2 inhibitors) in advanced CKD—continue them even at low eGFR unless acute deterioration occurs 14.

4. Don't order a renal biopsy reflexively—but do consider it when diagnosis is unclear and would change management, particularly for suspected glomerulonephritis or unexplained rapid decline 1, 2.

5. Don't forget to assess for proteinuria/albuminuria—this is an independent predictor of progression and cardiovascular risk, separate from eGFR 5, 6.